-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the FDA advisory committee voted unanimously in favor of Johnson & Johnson's single-dose COVID-19 vaccine candidate Ad26.
FDA COVID-19 infection
Johan Van Hoof, Global Head of Vaccine Research at Johnson & Johnson, said: "If authorized, our vaccine candidate will play a key role in the global fight against COVID-19.
Ad26.
ENSEMBLE test showed, Ad26.
Original source:
Original source:https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here